» Articles » PMID: 29562932

Rethinking the Treatment of Chronic Fatigue Syndrome-a Reanalysis and Evaluation of Findings from a Recent Major Trial of Graded Exercise and CBT

Overview
Journal BMC Psychol
Publisher Biomed Central
Specialty Psychology
Date 2018 Mar 23
PMID 29562932
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The PACE trial was a well-powered randomised trial designed to examine the efficacy of graded exercise therapy (GET) and cognitive behavioural therapy (CBT) for chronic fatigue syndrome. Reports concluded that both treatments were moderately effective, each leading to recovery in over a fifth of patients. However, the reported analyses did not consistently follow the procedures set out in the published protocol, and it is unclear whether the conclusions are fully justified by the evidence.

Methods: Here, we present results based on the original protocol-specified procedures. Data from a recent Freedom of Information request enabled us to closely approximate these procedures. We also evaluate the conclusions from the trial as a whole.

Results: On the original protocol-specified primary outcome measure - overall improvement rates - there was a significant effect of treatment group. However, the groups receiving CBT or GET did not significantly outperform the Control group after correcting for the number of comparisons specified in the trial protocol. Also, rates of recovery were consistently low and not significantly different across treatment groups. Finally, on secondary measures, significant effects were almost entirely confined to self-report measures. These effects did not endure beyond two years.

Conclusions: These findings raise serious concerns about the robustness of the claims made about the efficacy of CBT and GET. The modest treatment effects obtained on self-report measures in the PACE trial do not exceed what could be reasonably accounted for by participant reporting biases.

Citing Articles

CBT and graded exercise therapy studies have proven that ME/CFS and long COVID are physical diseases, yet no one is aware of that.

Vink M, Vink-Niese A Front Hum Neurosci. 2025; 19:1495050.

PMID: 39944089 PMC: 11814198. DOI: 10.3389/fnhum.2025.1495050.


Will psychology ever 'join hands' with disability studies? Opportunities and challenges in working towards structurally competent and disability-affirmative psychotherapy for energy limiting conditions.

Hunt J Med Humanit. 2024; 50(4):728-739.

PMID: 38914457 PMC: 11877048. DOI: 10.1136/medhum-2023-012877.


Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.

Arron H, Marsh B, Kell D, Khan M, Jaeger B, Pretorius E Front Immunol. 2024; 15:1386607.

PMID: 38887284 PMC: 11180809. DOI: 10.3389/fimmu.2024.1386607.


The Rationale, Evidence, and Adaptations to Pulmonary Rehabilitation for Chronic Respiratory Diseases Other Than COPD.

Evans R Respir Care. 2024; 69(6):697-712.

PMID: 38806225 PMC: 11147632. DOI: 10.4187/respcare.12089.


Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis.

Zhang Y, Wang L Front Endocrinol (Lausanne). 2024; 15:1373748.

PMID: 38660512 PMC: 11039924. DOI: 10.3389/fendo.2024.1373748.


References
1.
Keller B, Pryor J, Giloteaux L . Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment. J Transl Med. 2014; 12:104. PMC: 4004422. DOI: 10.1186/1479-5876-12-104. View

2.
Walwyn R, Potts L, McCrone P, Johnson A, DeCesare J, Baber H . A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan. Trials. 2013; 14:386. PMC: 4226009. DOI: 10.1186/1745-6215-14-386. View

3.
Sharpe M, Goldsmith K, Johnson A, Chalder T, Walker J, White P . Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. Lancet Psychiatry. 2015; 2(12):1067-74. DOI: 10.1016/S2215-0366(15)00317-X. View

4.
Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W . Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002; 87(3):235-41. PMC: 1767036. DOI: 10.1136/heart.87.3.235. View

5.
Hrobjartsson A, Emanuelsson F, Thomsen A, Hilden J, Brorson S . Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. Int J Epidemiol. 2014; 43(4):1272-83. PMC: 4258786. DOI: 10.1093/ije/dyu115. View